Te Ahumairangi Investment Management Ltd Has $7.34 Million Stock Position in HCA Healthcare, Inc. $HCA

Te Ahumairangi Investment Management Ltd cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,146 shares of the company’s stock after selling 268 shares during the quarter. HCA Healthcare accounts for about 1.3% of Te Ahumairangi Investment Management Ltd’s portfolio, making the stock its 21st biggest position. Te Ahumairangi Investment Management Ltd’s holdings in HCA Healthcare were worth $7,335,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of HCA. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare during the first quarter valued at about $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare in the 1st quarter valued at about $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the second quarter worth $27,000. Finally, Chung Wu Investment Group LLC bought a new position in HCA Healthcare in the 2nd quarter valued at $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HCA has been the subject of several research reports. Sanford C. Bernstein restated a “market perform” rating and set a $417.00 price target on shares of HCA Healthcare in a research report on Monday, October 27th. Truist Financial increased their target price on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. TD Cowen upped their price objective on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday, October 27th. UBS Group boosted their target price on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Finally, Oppenheimer increased their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $515.89 on Wednesday. The stock has a fifty day moving average of $445.26 and a 200-day moving average of $403.54. The stock has a market cap of $117.72 billion, a PE ratio of 19.94, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $517.40.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the previous year, the firm earned $4.90 EPS. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.